CALL US:022-2204 0015 / 16 / 17   isa@saffronmedia.in
HOME NEWS INGREDIENT MART EVENTS TOPICS INTERVIEW EDIT
 
News
 
Neethikrishna, Mumbai September 22 , 2020
The Union Ministry of Ayush has received 154 misleading advertisements on Ayush-related claims for COVID-19 treatment from different parts of the country till August 2020, said Union health minister, Dr Harsh Vardhan.

The ministry has issued directives to the state/UT authorities to initiate necessary action against the defaulters and alleged manufacturers /advertisers acting in contravention of the provisions of Drugs and Cosmetics Act, 1940 & Rules thereunder and Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules thereunder and to send the details of the clinical trials of Ayush medicines claimed for the prevention or treatment of COVID-19 for verification, he informed the Lok Sabha in a written reply.

The Union Ministry of Ayush has also issued public advisories and guidelines for the practitioners about the use of Ayush remedies to meet the challenge of COVID-19.

Dr Vardhan also said the instances of adverse effects due to consumption of above-mentioned immunity boosting drugs are not reported from the states/UTs. But, the incidences of COVID-19 related exaggerated claims and misleading advertisements of Ayush drugs have been reported by pharmacovigilance centres and forwarded to the concerned State Licensing Authorities/Drug Controllers and individual advertisers/manufacturers for corrective action.

The Union minister also informed that a number of medicinal products for immunity and health promotion have come in the market after Ministry of Ayush issued public advisories of Ayush-based healthcare during COVID-19 outbreak and promulgated a generic formulation.

The formulation is called Ayush Kwath/Ayush Kudineer/Ayush Joshanda comprising of Tulsi (Ocimum sanctum) leaves,Dalchini (Cinnamomumzeylanicum), Sunthi (Zingiber officinale) and Krishna Marich.

State Licensing Authorities have started granting license or approval for commercial manufacturing of such formulations under the provisions of Drugs and Cosmetics Rules, 1945 as applicable to Ayurvedic, Siddha and Unani (ASU) drugs.

As per the provisions of Drugs & Cosmetics Act, 1940 and Rules thereunder, approval of Ministry of Ayush is not required to manufacture for sale of Ayurvedic, Siddha and Unani drugs and such medicinal formulations. Powers of regulation and quality control of these drugs and formulations are vested with the State Governments, for which State Licensing Authorities/Drug Controllers are appointed.

Share This Story

Leave a Reply
Your name (required)   Your email (required)
         
Website (required)
   
CommenT
 
Enter Code (Required)

 

 

 
INGREDIENT MART

RECENT NEWS

TOPICS
The healthy snacks segment is estimated to be around 2 per cent of the overall snacks market in India, according to expe ...

 

MAIN LINKS OUR SERVICES OTHER PRODUCTS ONLINE MEDIA  
 
About Us
Contact Us
News Archives
 

Product Finder
Features and Articles
News
 
Chronicle Pharmabiz
Food & Bevergae News
Ingredients South Asia
 
Media Information
Rate Card
Advertise
 
 
Copyright © 2013 Saffron Media Pvt Ltd. All Rights Reserved.
Best View in Internet Explorer(9.0) or Firefox(26.0)